Summit Speaker

Olivier Elemento

Professor of Physiology and Biophysics at Weill Cornell Medicine and Cornell University

Dr. Elemento is a professor of physiology and biophysics at Weill Cornell Medicine (WCM) and Cornell University. Since 2017, he has been the Director of the Caryl and Israel Englander Institute for Precision Medicine (https://eipm.weill.cornell.edu/). The Englander Institute is a multidisciplinary institute that draws over 100 faculty members from nearly all basic and clinical departments at Cornell University. The Englander Institute’s mission is to use genomics, artificial intelligence (AI), patient-derived models and other technologies to develop and bring highly personalized medicine to patients at Weill Cornell’s affiliated hospital, NewYork Presbyterian Hospital (NYPH) and elsewhere. The Institute also fosters patient-centered basic and clinical research in the areas of genomics, systems biology, AI and data science. Dr. Elemento is funded by numerous NIH grants, foundation grants, NIH contracts and industry alliances. He has published over 430 papers in the area of precision medicine, genomics, computational biology, artificial intelligence, systems biology and drug discovery. He has led the development of novel clinical (CLIA) genomics assays including whole-exome sequencing offered to patients at WCM/NYPH and is currently leading a large multi-cancer effort to bring patient-derived cell models (organoids) and high-throughput drug screening into clinical use at WCM/NYPH. Dr Elemento is also Associate Director of the Clinical and Translational Science Center (CTSC) and Associate Director of the Institute for Computational Biomedicine. Dr. Elemento co-founded two venture capital-funded companies: Volastra Therapeutics and OneThree Biotech. He serves on the scientific advisory board of Volastra, OneThree Biotech as well as of Owkin, Freenome, Harmonic, Pionyr, Champions Oncology and several other companies.

Speaker Home